These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15077685)
1. Antiretroviral efficacy of a 98% solution of glycerol or ethylene oxide for inactivation of feline leukemia virus in bone. Coronado GS; Swenson CL Am J Vet Res; 2004 Apr; 65(4):436-9. PubMed ID: 15077685 [TBL] [Abstract][Full Text] [Related]
2. Effects of a 98% solution of glycerol or sterilization with ethylene oxide on FeLV in bone allografts and effects on bone incorporation of allografts in cats. Coronado GS; Swenson CL; Martinez SA; Burkhardt KS; Arnoczky SP Am J Vet Res; 2000 Jun; 61(6):665-71. PubMed ID: 10850843 [TBL] [Abstract][Full Text] [Related]
3. The location in cartilage of infectious retrovirus in cats infected with feline leukemia virus. Arnoczky SP; Swenson C; Egerbacher M; Gardner K; Caballero O; Burns M J Bone Joint Surg Am; 2007 Sep; 89(9):2030-6. PubMed ID: 17768202 [TBL] [Abstract][Full Text] [Related]
5. Feline leukaemia provirus load during the course of experimental infection and in naturally infected cats. Hofmann-Lehmann R; Huder JB; Gruber S; Boretti F; Sigrist B; Lutz H J Gen Virol; 2001 Jul; 82(Pt 7):1589-1596. PubMed ID: 11413369 [TBL] [Abstract][Full Text] [Related]
6. Feline leukaemia virus status of Australian cats with lymphosarcoma. Gabor LJ; Jackson ML; Trask B; Malik R; Canfield PJ Aust Vet J; 2001 Jul; 79(7):476-81. PubMed ID: 11549046 [TBL] [Abstract][Full Text] [Related]
7. Antiviral therapy in cats progressively infected with feline leukaemia virus: lessons from a series of 18 consecutive cases from Australia. Westman ME; Hall E; Norris JM; Meili T; Hofmann-Lehmann R; Malik R Aust Vet J; 2024 Sep; 102(9):453-465. PubMed ID: 39042044 [TBL] [Abstract][Full Text] [Related]
8. Incidence of persistent viraemia and latent feline leukaemia virus infection in cats with lymphoma. Stützer B; Simon K; Lutz H; Majzoub M; Hermanns W; Hirschberger J; Sauter-Louis C; Hartmann K J Feline Med Surg; 2011 Feb; 13(2):81-7. PubMed ID: 21131219 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow up of feline leukemia virus infection and characterization of viral RNA loads using molecular methods in tissues of cats with different infection outcomes. Helfer-Hungerbuehler AK; Widmer S; Kessler Y; Riond B; Boretti FS; Grest P; Lutz H; Hofmann-Lehmann R Virus Res; 2015 Feb; 197():137-50. PubMed ID: 25553598 [TBL] [Abstract][Full Text] [Related]
10. Analytical validation of a reference laboratory ELISA for the detection of feline leukemia virus p27 antigen. Buch JS; Clark GH; Cahill R; Thatcher B; Smith P; Chandrashekar R; Leutenegger CM; O'Connor TP; Beall MJ J Vet Diagn Invest; 2017 Sep; 29(5):654-659. PubMed ID: 28548572 [TBL] [Abstract][Full Text] [Related]
11. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats. Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a Revised Point-of-Care Test for the Detection of Feline Leukaemia p27 Antigen and Anti-p15E Antibodies in Cats. Giselbrecht J; Jähne S; Bergmann M; Meli ML; Teichmann-Knorrn S; Zablotski Y; Pennisi MG; Layachi N; Serra R; Bo S; Hofmann-Lehmann R; Hartmann K Viruses; 2024 Apr; 16(4):. PubMed ID: 38675954 [TBL] [Abstract][Full Text] [Related]
13. Shedding of feline leukemia virus RNA in saliva is a consistent feature in viremic cats. Gomes-Keller MA; Tandon R; Gönczi E; Meli ML; Hofmann-Lehmann R; Lutz H Vet Microbiol; 2006 Jan; 112(1):11-21. PubMed ID: 16303261 [TBL] [Abstract][Full Text] [Related]
14. Adeno-Associated Vector-Delivered CRISPR/ Helfer-Hungerbuehler AK; Shah J; Meili T; Boenzli E; Li P; Hofmann-Lehmann R Viruses; 2021 Aug; 13(8):. PubMed ID: 34452500 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of Different Courses of Feline Leukaemia Virus Infection in Four European Countries. Giselbrecht J; Jähne S; Bergmann M; Meli ML; Pineroli B; Boenzli E; Teichmann-Knorrn S; Zablotski Y; Pennisi MG; Layachi N; Serra R; Bo S; Hofmann-Lehmann R; Hartmann K Viruses; 2023 Aug; 15(8):. PubMed ID: 37632060 [TBL] [Abstract][Full Text] [Related]
16. BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines. Moll GM; Swenson CL; Yuzbasiyan-Gurkan V Viruses; 2023 Aug; 15(9):. PubMed ID: 37766260 [TBL] [Abstract][Full Text] [Related]
17. Comparison of three feline leukaemia virus (FeLV) point-of-care antigen test kits using blood and saliva. Westman ME; Malik R; Hall E; Sheehy PA; Norris JM Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():88-96. PubMed ID: 28131385 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo evidence that the antiviral activity of 2',3'-dideoxycytidine is target cell dependent in a feline retrovirus animal model. Polas PJ; Swenson CL; Sams R; Cheney CM; Hayes KA; Tarr MJ; Kociba GJ; Mathes LE Antimicrob Agents Chemother; 1990 Jul; 34(7):1414-21. PubMed ID: 2167039 [TBL] [Abstract][Full Text] [Related]
19. Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection. Major A; Cattori V; Boenzli E; Riond B; Ossent P; Meli ML; Hofmann-Lehmann R; Lutz H Vet Res; 2010; 41(2):17. PubMed ID: 19861115 [TBL] [Abstract][Full Text] [Related]